Cadwalader Advises Population Health Investment Co. on $150 Million IPO

November 18, 2020

Cadwalader is advising Population Health Investment Co., Inc. (Nasdaq: PHICU) on its $150 million initial public offering of 15,000,000 units at a price of $10.00 per unit. The offering was priced on November 17 and is expected to close November 20.

Population Health Investment Co., Inc. is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While Population Health may pursue an initial business combination in any industry, sector, or geographic region, it intends to focus on companies or divisions of companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. The company was founded by Dr. Clive Meanwell and Ian Read.

The Cadwalader team includes Corporate partner Greg Patti and associates Frank Bozzi and Erica Hogan and Tax partner Jason Schwartz and associate Matthew Seitz.

COVID-19 Resource Center

  • Access our insights on the impact of COVID-19 to help you navigate this unprecedented environment.

To assist individuals in working from home during the coronavirus social-distancing period, Cadwalader is providing clients and friends free access to our legal research platform, the Cadwalader Cabinet.